A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)

Clinical trial NCT07242469 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07242469
Sponsor: Merck Sharp & Dohme LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2025-12-22
Primary completion: 2026-09-03
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.